Mirium Pharmaceuticals Finds $120M
socalTECH
NOVEMBER 7, 2018
San Diego-based Mirium Pharmaceuticals , which is developing treatments for rare liver diseases, announced on Wednesday morning that it has raised $120M in a Series A funding round. The funding was led by New Enterprise Associates (NEA), and also included Deerfield Management, Frazier Healthcare Partners, Novo Holdings A/S, Pappas Capital, RiverVest Venture Partners and Rock Springs Capital.
Let's personalize your content